Infectious complications related to liver transplants

Česká verzia

Authors: Vladimír Mejzlík; Libuše Husová; Milan Kuman; Soňa Štěpánková; Jiří Ondrášek; Petr Němec
Authors place of work: Centrum kardiovaskulární a transplantační chirurgie, Brno
Published in the journal: Vnitř Lék 2017; 63(7-8): 527-530
Category: Reviews

Summary

Infection is a feared complication in the process of transplantation. The study discusses sources of infection, screening of infection and risk factors for infection, time occurrence of individual infections during the peritransplantation and posttransplantation course. It describes the most frequent forms of bacterial, viral and mycotic infections. It specifies efficient prophylactic measures that considerably reduce the risk of infection following liver transplantation.

Key words:
bacterial infection – cytomegalovirus (CMV) – EB virus (EBV) – hepatitis B (HBV) – hepatitis C (HCV) – liver transplantation – mycotic infection prophylaxis – risk factors – viral infection

Zdroje

1. Sun HY, Cacciarelli TV, Singh N. Impact of pretransplant infections on clinical outcomes of liver transplant recipients. Liver Transplantation 2010; 16(2): 222–228. Dostupné z DOI: <http://dx.doi.org/10.1002/lt.21982>.

2. Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med 1998; 338(4): 1741–1751.

3. Romero FA, Razonable RR. Infections in liver transplant recipients. World J Hepatol 2011; 3(4): 83–92. Dostupné z DOI: <http://dx.doi.org/10.4254/wjh.v3.i4.83>.

4. Brayman KL, Stephanian E, Matas AJ et al. Analysis of infectious complications occurring after solid-organ transplantation. Arch Surg 1992; 127(1): 38–48.

5. Singh N, Wagener NM, Gayowski T et al. Trends in invasive fungal infections in liver transplant recipients: Correlation with evolution in transplant practices. Transplantation 2002; 73(1): 63–67.

6. Eschenauer GA, Lam SW, Carver PL. Antifungal prophylaxis in liver transplant recipients. Liver Transplant 2009; 15(8): 842–858. Dostupné z DOI: <http://dx.doi.org/10.1002/lt.21826>. Erratum in Liver Transpl 2010; 16(6): 797–805.

7. Fortun J, Martin-Davila P, Moreno S et al. Risk factors for invasive aspergillosis in liver transplant recipients. Liver Transpl 2002; 8(11): 1065–1070.

8. Liang TJ, Ghany MG. Current and future therapies for hepatitis C virus infection. N Engl J Med 2013; 368(20): 1907–1917. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMra1213651>.

9. Kalil AC, Mindru C, Botha JF et al. Risk of cytomegalovirus disease in high-risk liver transplant recipients on valganciclovir Prophylaxis: A systematic review and meta-analysis. Liver Transpl 2012; 18(12): 1440–1447. Dostupné z DOI: <http://dx.doi.org/10.1002/lt.23530>.

10. Torre-Cisneros H, de la Mata M, Lopez-Cillero P et al. Effectiveness of daily low-dose cotrimoxazole prophylaxis for Pneumocystis carinii pneumonia in liver transplantation – an open clinical trial. Transplantation 1996; 62(10): 1519–1521.

11. Holt D, Winston J, Busuttil R et al. Infections after Liver Transplantation. In: Ronald W. Busuttil RW, Klintmalm GB (eds).Transplantation of The Liver. 3rd ed. 2015: 1006–1030. ISBN: 978–1-4557–0268–8. Dostupné z DOI: <https://doi.org/10.1016/B978–1-4557–0268–8.12001–9>.